Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine

(2009) Murielle Surquin et al.   KIDNEY INTERNATIONAL

Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients

(2008) Jiri Beran   EXPERT OPINION ON BIOLOGICAL THERAPY

Persistence of Hepatitis B Vaccine Immunity in Hemodialysis Patients

(2008) Amitis Ramezani et al.   THERAPEUTIC APHERESIS AND DIALYSIS

The global impact of vaccination against hepatitis B: A historical overview

(2008) Alessandro R. Zanetti et al.   VACCINE

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

(2008) Pierre Vandepapelière et al.   VACCINE

Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients

(2007) A. Ramezani et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients

(2007) N.C.T. Kong et al.   KIDNEY INTERNATIONAL